Trials / Conditions / Stage IV Fallopian Tube Cancer

Stage IV Fallopian Tube Cancer

24 registered clinical trials studyying Stage IV Fallopian Tube Cancer — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube C NCT05659381	GOG Foundation	Phase 3
Recruiting	A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970	Memorial Sloan Kettering Cancer Center	N/A
Recruiting	Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With A NCT04811703	Hospices Civils de Lyon	Phase 1
Unknown	Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites NCT04267575	Jerome Canady, M.D.	N/A
Completed	Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovari NCT03188432	Wake Forest University Health Sciences	Phase 2
Withdrawn	PET Imaging of Ovarian Carcinoma With 18F-FSPG NCT02872519	Vanderbilt-Ingram Cancer Center	EARLY_Phase 1
Withdrawn	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Perito NCT02833506	Roswell Park Cancer Institute	Phase 1
Terminated	IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, o NCT03029611	University of Washington	Phase 2
Withdrawn	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian NCT02470559	Barbara Ann Karmanos Cancer Institute	Phase 1
Completed	Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone NCT02122185	University of Chicago	Phase 2
Completed	Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavi NCT02111941	Mayo Clinic	EARLY_Phase 1
Withdrawn	Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or NCT01982487	Roswell Park Cancer Institute	Phase 1 / Phase 2
Completed	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Pri NCT01536054	Roswell Park Cancer Institute	Phase 1
Completed	Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri NCT01606241	Mayo Clinic	Phase 1
Terminated	Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap NCT01275664	Gynecologic Oncology Group	N/A
Completed	OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca NCT00857545	Gynecologic Oncology Group	Phase 2
Completed	RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Canc NCT01175343	National Cancer Institute (NCI)	Phase 2
Completed	Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone NCT01080521	Gynecologic Oncology Group	—
Completed	Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian NCT02311907	Alliance for Clinical Trials in Oncology	Phase 3
Completed	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126	National Cancer Institute (NCI)	Phase 2
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—
Completed	Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal NCT00388037	National Cancer Institute (NCI)	Phase 2
Completed	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian NCT00262847	National Cancer Institute (NCI)	Phase 3
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—